Macrolide-lincosamide-streptogramin resistance phenotypes and genotypes of coagulase-positive Staphylococcus aureus and coagulase-negative staphylococcal isolates from bovine mastitis

BMC Veterinary Research

Xin Zhao¹  Huping Xue²  Zhiping Zhang²  Weiwei Feng²  Longping Li² 

[1] Department of Animal Science, McGill University, 21,111 Lakeshore, Ste. Anne de Bellevue H9X 3 V9, QC, Canada;College of Animal Science and Technology, Northwest A&F University, Yang Ling, Shaanxi, P. R. China

关键词: Bovine milk;    Staphylococci;    Disk-diffusion induction test;    Macrolide resistance;   

Others  :  1224416
DOI  :  10.1186/s12917-015-0492-8

 received in 2015-01-18, accepted in 2015-07-16,  发布年份 2015

【 摘 要 】

Background

There are limited data available on macrolide-lincosamide-streptogramin (MLS) resistance of Staphylococcus aureus (S. aureus) and coagulase-negative staphylococci (CoNS) from bovine milk in China. To address this knowledge gap, MLS resistance was determined in 121 S. aureus and 97 CoNS isolates. Minimum inhibitory concentrations (MICs) of MLS antibiotics were determined by an agar dilution method, while differentiation of MLS phenotypes was performed by a double-disc diffusion test. MLS resistance genotypes were determined by PCR for corresponding resistance genes.

Results

Forty (33.1 %) S. aureus and 65 (67.0 %) CoNS were resistant to erythromycin, whereas all 218 isolates were susceptible to quinupristin/dalfopristin. Among 40 erythromycin-resistant (ER-R) S. aureus and 65 ER-R CoNS isolates, 38 S. aureus and 40 CoNS isolates exhibited the inducible MLS (iMLS) resistance phenotype and 2 S. aureus and 20 CoNS isolates expressed the constitutive MLS resistance (cMLS) phenotype. At the same time, 5 CoNS isolates exhibited resistance to erythromycin but susceptibility to clindamycin (the MS phenotype). An inactivating enzyme gene lnu(A), methylase genes erm(C) and erm(B), efflux genes msr(A)/msr(B), a phosphotransferase gene mph(C), an esterase gene ere(A) and the streptogramin resistance determinant vga(A) were detected individually or in combinations. Among them, genes lnu(A), erm(C) and mph(C) predominated. The ereA gene was detected for the first time in staphylococci of bovine milk origin. Resistance genes also existed in erythromycin-susceptible isolates.

Conclusions

Our study demonstrated a high level of resistance to MLS antibiotics in staphylococci from bovine mastitic milk, especially with a high rate of the iMLS phenotype in S. aureus isolates. These data suggest that MLS antibiotics should be used judiciously to treat or prevent bovine mastitis caused by staphylococci.

【 授权许可】

   
2015 Li et al.

【 参考文献 】

• [1]Pyorala S, Taponen S. Coagulase-negative staphylococci-emerging mastitis pathogens. Vet Microbiol. 2009; 134(1-2):3-8.
• [2]Taponen S, Pyorala S. Coagulase-negative staphylococci as cause of bovine mastitis-Not so different from Staphylococcus aureus? Vet Microbiol. 2009; 134(1-2):29-36.
• [3]Frey Y, Rodriguez JP, Thomann A, Schwendener S, Perreten V. Genetic characterization of antimicrobial resistance in coagulase-negative staphylococci from bovine mastitis milk. J Dairy Sci. 2013; 96(4):2247-2257.
• [4]Sawant AA, Gillespie BE, Oliver SP. Antimicrobial susceptibility of coagulase-negative staphylococcus species isolated from bovine milk. Vet Microbiol. 2009; 134(1-2):73-81.
• [5]Wang Y, Wu CM, Lu LM, Ren GWN, Cao XY, Shen JZ. Macrolide-lincosamide-resistant phenotypes and genotypes of Staphylococcus aureus isolated from bovine clinical mastitis. Vet Microbiol. 2008; 130(1-2):118-125.
• [6]McDougall S, Agnew KE, Cursons R, Hou XX, Compton CRW. Parenteral treatment of clinical mastitis with tylosin base or penethamate hydriodide in dairy cattle. J Dairy Sci. 2007; 90(2):779-789.
• [7]Poehlsgaard J, Douthwaite S. The bacterial ribosome as a target for antibiotics. Nat Rev Microbiol. 2005; 3(11):870-881.
• [8]Depardieu F, Podglajen I, Leclercq R, Collatz E, Courvalin P. Modes and modulations of antibiotic resistance gene expression. Clin Microbiol Rev. 2007; 20(1):79-114.
• [9]Leclercq R. Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications. Clin Infect Dis. 2002; 34(4):482-492.
• [10]Lüthje P, von Köckritz-Blickwede M, Schwarz S. Identification and characterization of nine novel types of small staphylococcal plasmids carrying the lincosamide nucleotidyltransferase gene lnu(A). J Antimicrob Chemother. 2007; 59(4):600-606.
• [11]Roberts MC. Resistance to tetracycline, macrolide-lincosamide-streptogramin, trimethoprim, and sulfonamide drug classes. Mol Biotechnol. 2002; 20(3):261-283.
• [12]Lüthje P, Schwarz S. Antimicrobial resistance of coagulase-negative staphylococci from bovine subclinical mastitis with particular reference to macrolide-lincosamide resistance phenotypes and genotypes. J Antimicrob Chemother. 2006; 57(5):966-969.
• [13]Ochoa-Zarzosa A, Loeza-Lara PD, Torres-Rodriguez F, Loeza-Angeles H, Mascot-Chiquito N, Sanchez-Baca S, Lopez-Meza JE. Antimicrobial susceptibility and invasive ability of Staphylococcus aureus isolates from mastitis from dairy backyard systems. Anton Leeuw Int J G. 2008; 94(2):199-206.
• [14]Li LP, Zhou LX, Wang LH, Xue HP, Zhao X. Characterization of methicillin-resistant and -susceptible staphylococcal isolates from bovine milk in Northwestern China. PLoS One. 2015; 10(3):e0116699.
• [15]Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals: Informational supplement. CLSI document 2004, M31-S1. Wayne, PA
• [16]Use of antimicrobials and occurrence of antimicrobial resistance in Sweden. SWEDRES-SVARM Document, Solna/Uppsala; 2012.
• [17]Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. CLSI document. 2011; 31(1):M100-S21.
• [18]Lina G, Quaglia A, Reverdy ME, Leclercq R, Vandenesch F, Etienne J. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob Agents Chemother. 1999; 43(5):1062-1066.
• [19]Sutcliffe J, Grebe T, TaitKamradt A, Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother. 1996; 40(11):2562-2566.
• [20]Werner G, Cuny C, Schmitz FJ, Witte W. Methicillin-resistant, quinupristin-dalfopristin-resistant Staphylococcus aureus with reduced sensitivity to glycopeptides. J Clin Microbiol. 2001; 39(10):3586-3590.
• [21]Entorf M, Feßler AT, Kadlec K, Kaspar H, Mankertz J, Peters T, Schwarz S. Tylosin susceptibility of staphylococci from bovine mastitis. Vet Microbiol. 2014; 171(3-4):368-373.
• [22]Pfister P, Jenni S, Poehlsgaard J, Thomas A, Douthwaite S, Ban N, Bottger EC. The structural basis of macrolide-ribosome binding assessed using mutagenesis of 23 S rRNA positions 2058 and 2059. J Mol Biol. 2004; 342(5):1569-1581.
• [23]Lüthje P, Schwarz S. Molecular analysis of constitutively expressed erm(C) genes selected in vitro in the presence of the non-inducers pirlimycin, spiramycin and tylosin. J Antimicrob Chemother. 2007; 59(1):97-101.
• [24]Daurel C, Huet C, Dhalluin A, Bes M, Etienne J, Leclercq R. Differences in potential for selection of clindamycin-resistant mutants between inducible erm(A) and erm(C) Staphylococcus aureus genes. J Clin Microbiol. 2008; 46(2):546-550.
• [25]de Vries LE, Christensen H, Agerso Y. The diversity of inducible and constitutively expressed erm(C) genes and association to different replicon types in staphylococci plasmids. Mobile Genetic Elements. 2012; 2(2):72-80.
• [26]Martineau F, Picard FJ, Lansac N, Menard C, Roy PH, Ouellette M, Bergeron MG. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother. 2000; 44(2):231-238.
• [27]Spiliopoulou I, Petinaki E, Papandreou P, Dimitracopoulos G. erm(C) is the predominant genetic determinant for the expression of resistance to macrolides among methicillin-resistant Staphylococcus aureus clinical isolates in Greece. J Antimicrob Chemother. 2004; 53(5):814-817.